Prucalopride Succinate; Reconsideration of NY D83726
Reasoning
Prucalopride Succinate; Reconsideration of NY D83726
Cite this ruling
CBP Ruling 962562 (30049090): Prucalopride Succinate; Reconsideration of NY D83726
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of RIBASPHERE™ (ribavirin) capsules
The tariff classification of cough suppressant lozenges from England.
The tariff classification of dietary supplements from Italy
The tariff classification of IQUIX® (levofloxacin ophthalmic solution) 1.5%, imported in bulk and measured-dose forms, from Finland
The tariff classification of Pulmozyme® (dornase alfa) Inhalation Solution; Raptiva® (Efalizumab) for injection, subcutaneous; Rituxan® (Rituximab); TNKase™ (Tenecteplase); and Xolair® (Omalizumab) for subcutaneous use